


Sublimity Therapeutics Revenue
Pharmaceutical Manufacturing • Dublin, Co Dublin, Ireland • 1-10 Employees
Sublimity Therapeutics revenue & valuation
| Annual revenue | $7,500,000 |
| Revenue per employee | $938,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Pharmaceutical Manufacturing industry and current estimated revenues | $24,000,000 |
| Total funding | No funding |
Key Contact at Sublimity Therapeutics
Bernard Mc Donald
Director Of Quality & Cmc
Company overview
| Headquarters | DCU Alpha Innovation Campus, Old Finglas Road, Dublin, 11 D11 KXN4, IE |
| Phone number | +3532025041408 |
| Website | |
| NAICS | 3254 |
| SIC | 283 |
| Employees | 1-10 |
| Socials |
About Sublimity Therapeutics
Sublimity Therapeutics is a clinical-stage biotechnology company dedicated to identifying and developing meaningful new therapies for unmet clinical needs in gastrointestinal and immunological diseases. Led by a team of industry innovators and leveraging our Single-Multiple Pill (SmPill®) technology, we are advancing a diverse pipeline of oral small molecules that have the potential to make important contributions to human health. Our lead asset ST-0529 is currently being evaluated in the AURORA (CYC-202) Study, a Phase 2b clinical trial for moderate to severe Ulcerative Colitis.
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Employees by Department
Sublimity Therapeutics has 3 employees across 2 departments.
Departments
Number of employees
Sublimity Therapeutics Tech Stack
Discover the technologies and tools that power Sublimity Therapeutics's digital infrastructure, from frameworks to analytics platforms.
CDN
Miscellaneous
Frequently asked questions
4.8
40,000 users



